NYSE American · Medical Instruments & Supplies · USD
Milestone Scientific Inc. (MLSS) Stock Analysis
Milestone Scientific Inc. (MLSS) is a Medical Instruments & Supplies stock listed on NYSE American and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
MLSS Key Statistics
As of Oct 21, 2026Trading
- Open
- $0.33
- Previous Close
- $0.34
- Day's Range
- 0.31–0.34
- 52-Week Range
- 0.22–0.58
- Volume
- 129.14K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 1.13
Valuation
- Market Cap
- $28.09M
- P/E Ratio
- unprofitable
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 2.98
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −0.04
Financials (FY)
- Revenue (FY)
- $8.97M+3.99%
- Net Income (FY)
- −$5.72M
- Profit marginThe share of revenue left as profit after all costs and taxes.
- −43.98%
- Shares Outstanding
- 90.61M
- 1-Year Return
- −31.11%
Dividend and dates
- Earnings Date
- November 12, 2026
- Avg Volume
- 123.48K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, MLSS closed at $0.31, −31.11% over 1 year.
Milestone Scientific Inc. (MLSS) has a market capitalization of $28.09M.
In fiscal 2025, MLSS reported revenue of $8.97M.
MLSS Stock Return by Calendar Year
Milestone Scientific Inc. (MLSS) 10-year return: what $10,000 became
- 1 year
- $10,000 $6,889
- −31.11%
- 5 years
- $10,000 $1,455
- −85.45%
- 10 years
- $10,000 $1,512
- −84.88%
If you had invested $10,000 in Milestone Scientific Inc. (MLSS) 10 years ago, at the close on October 21, 2016, it would have been worth $1,512 at the close on October 21, 2026: −84.88% in total, −17.21% a year. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +14.81% |
| 2025 | −71.88% |
| 2024 | +39.13% |
| 2023 | +43.75% |
| 2022 | −76.70% |
| 2021 | −2.83% |
| 2020 | +52.52% |
| 2019 | +321.21% |
| 2018 | −72.03% |
| 2017 | −15.71% |
| 2016 (partial year) | −45.31% |
As of October 21, 2026.
MLSS Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $8.97M | −$5.72M | −63.8% |
| 2024 | $8.63M | −$4.71M | −54.6% |
| 2023 | $9.83M | −$6.93M | −70.5% |
| 2022 | $8.81M | −$8.71M | −98.9% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $8.97M | $6.41M | −$5.70M | −$5.72M | −63.8% |
| 2024 | $8.63M | $6.43M | −$6.76M | −$4.71M | −54.6% |
| 2023 | $9.83M | $6.79M | −$7.11M | −$6.93M | −70.5% |
| 2022 | $8.81M | $4.90M | −$8.83M | −$8.71M | −98.9% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
MLSS Valuation vs Medical Instruments & Supplies Median
Median of 50 stocks| Metric | MLSS | Medical Instruments & Supplies median | vs median |
|---|---|---|---|
| P/S ratio | 2.98 | 2.60 | 15% above |
| Profit margin | −43.98% | 1.62% | 45.6 pts below |
Medians across 50 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business
YahooMilestone Scientific Announces Pain and Spine Specialists and Dr. Sudhir Rao as CompuFlo® Development Partner and Advisor
YahooMilestone Scientific Files Prospectus To Offer Securities Up To $45M
BenzingaMilestone Scientific Directors Convert $465K Loans Into Equity, Eliminating Debt And Achieving Debt‑Free Balance Sheet
BenzingaMilestone Scientific Inc. (MLSS) Q2 2026 Earnings Call Transcript
SeekingAlphaConference Call: Milestone Scientific Affirms FY2026 Sales Guidance of $9.800M-$10.200M vs $9.910M Est
Benzinga
All 10 articles ↓Show fewer ↑
Conference Call: Milestone Scientific Sees Q3 Sales $2.300M-$2.500M vs $2.510M Est
BenzingaTranscript: Milestone Scientific Q2 2026 Earnings Conference Call
BenzingaMilestone Scientific Q2 EPS $(0.01), Inline, Sales $2.841M Beat $2.700M Estimate
BenzingaMilestone Scientific Announces Strategic Federal Distribution Partnership with Red One Medical to Expand Commercial Access for the CompuFlo® Epidural System
Yahoo
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Medical Instruments & Supplies Stocks
Intuitive Surgical, Inc.
$151.25B
BDXBecton, Dickinson and Company
$52.79B
MDLNMedline Inc.
$47.51B
RMDResMed Inc.
$34.63B
ALCAlcon Inc.
$32.60B
WSTWest Pharmaceutical Services, Inc.
$27.69B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
UNHUnitedHealth Group Incorporated
$374.30B
MRKMerck & Co., Inc.
$369.78B








